K. Shaw Lamberson

K. Shaw Lamberson, M.D. has extensive experience in pharmacovigilance and patient safety, currently serving as Vice President and Head of Pharmacovigilance Regions at Bayer since January 2011, with previous roles including Vice President of North America Pharmacovigilance and US Pharmacovigilance. Prior experience at Eli Lilly and Company from October 2000 to January 2010 includes positions as Senior Director of Global Patient Safety, Director of Global Physician Development, Director of US Women's Health & Reproductive Medicine, and Senior Clinical Research Physician. K. Shaw Lamberson holds an MD in Internal Medicine with a focus on Rheumatology from Indiana University School of Medicine and a BA in Biology from Indiana University Bloomington.